Science Explorer Back to mapMap
Discussion
Company · Cambridge · United Kingdom

Napp Pharmaceuticals (United Kingdom)

napp.co.ukROR OpenAlex
Research works
80
▼ 30% vs 2018-21
Citations
3k
38.2 per fractional work
Top-10% rate
7.2%
all institutions 10.0%
Open access
18%
world 40%
International
21%
world 18%
Napp Pharmaceuticals (United Kingdom)

Not ranked overall: Napp Pharmaceuticals (United Kingdom) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Napp Pharmaceuticals (United Kingdom) work in?

In all years, 49% of research at Napp Pharmaceuticals (United Kingdom) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (47%), Biochemistry, Genetics and Molecular Biology (17%), Chemistry (9%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 39 fractional works · 48.7% of its workMedicine: 37 fractional works · 46.8% of its workEpidemiology: 6 fractional works · 7.1% of its workSurgery: 3 fractional works · 4.3% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 4.1% of its workPharmacology: 3 fractional works · 3.2% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 3.1% of its workOncology: 2 fractional works · 2.7% of its workAnesthesiology and Pain Medicine: 2 fractional works · 2.3% of its workPulmonary and Respiratory Medicine: 2 fractional works · 2.3% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 2.0% of its workInfectious Diseases: 2 fractional works · 2.0% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 1.9% of its workPhysiology: 1 fractional works · 1.8% of its workRheumatology: 1 fractional works · 1.7% of its workPsychiatry and Mental health: 1 fractional works · 1.6% of its workGastroenterology: 1 fractional works · 1.5% of its workReproductive Medicine: 1 fractional works · 1.0% of its workComplementary and alternative medicine: 1 fractional works · 1.0% of its workEmergency Medicine: 1 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.3% of its workImmunology and Allergy: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 1 fractional works · 1.0% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workPharmacy: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workVeterinary: 1 fractional works · 0.7% of its workSmall Animals: 1 fractional works · 0.7% of its workDentistry: 0 fractional works · 0.2% of its workPeriodontics: 0 fractional works · 0.2% of its workLife Sciences: 26 fractional works · 32.1% of its workBiochemistry, Genetics and Molecular Biology: 13 fractional works · 16.5% of its workMolecular Biology: 9 fractional works · 11.1% of its workGenetics: 3 fractional works · 4.0% of its workBiotechnology: 0 fractional works · 0.4% of its workCancer Research: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workClinical Biochemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 5 fractional works · 5.7% of its workFood Science: 1 fractional works · 1.8% of its workPlant Science: 1 fractional works · 1.5% of its workAnimal Science and Zoology: 1 fractional works · 1.0% of its workEcology, Evolution, Behavior and Systematics: 1 fractional works · 0.9% of its workInsect Science: 0 fractional works · 0.4% of its workAgronomy and Crop Science: 0 fractional works · 0.2% of its workImmunology and Microbiology: 4 fractional works · 5.1% of its workImmunology: 2 fractional works · 3.0% of its workMicrobiology: 1 fractional works · 1.5% of its workVirology: 1 fractional works · 0.7% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 3.0% of its workPharmaceutical Science: 2 fractional works · 2.2% of its workPharmacology: 0 fractional works · 0.6% of its workToxicology: 0 fractional works · 0.3% of its workNeuroscience: 1 fractional works · 1.6% of its workCognitive Neuroscience: 1 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workPhysical Sciences: 12 fractional works · 15.6% of its workChemistry: 7 fractional works · 9.2% of its workOrganic Chemistry: 4 fractional works · 5.1% of its workAnalytical Chemistry: 2 fractional works · 2.5% of its workPhysical and Theoretical Chemistry: 1 fractional works · 1.0% of its workSpectroscopy: 1 fractional works · 0.6% of its workComputer Science: 2 fractional works · 2.1% of its workComputational Theory and Mathematics: 2 fractional works · 2.1% of its workEngineering: 2 fractional works · 1.9% of its workControl and Systems Engineering: 1 fractional works · 0.8% of its workElectrical and Electronic Engineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.4% of its workMaterials Science: 1 fractional works · 1.3% of its workMaterials Chemistry: 1 fractional works · 1.3% of its workPhysics and Astronomy: 0 fractional works · 0.6% of its workStatistical and Nonlinear Physics: 0 fractional works · 0.4% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.2% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workEnvironmental Science: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.1% of its workSocial Sciences: 3 fractional works · 3.7% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.2% of its workEconomics and Econometrics: 1 fractional works · 0.9% of its workFinance: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 1 fractional works · 0.9% of its workBusiness and International Management: 0 fractional works · 0.4% of its workStrategy and Management: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workArts and Humanities: 1 fractional works · 0.8% of its workMusic: 0 fractional works · 0.4% of its workLiterature and Literary Theory: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 1 fractional works · 0.7% of its workPolitical Science and International Relations: 0 fractional works · 0.4% of its workSociology and Political Science: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.1% of its workALL ITS WORKNappPharmaceuticals…80fractional works, all years
Life Sciences32%Physical Sciences16%Health Sciences49%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Medicine3746.8%
    2. Health Professions11.0%
    3. Veterinary10.7%
    4. Dentistry00.2%
    1. Biochemistry, Genetics and Molecular Biology1316.5%
    2. Agricultural and Biological Sciences55.7%
    3. Immunology and Microbiology45.1%
    4. Pharmacology, Toxicology and Pharmaceutics23.0%
    5. Neuroscience11.6%
    1. Chemistry79.2%
    2. Computer Science22.1%
    3. Engineering21.9%
    4. Materials Science11.3%
    5. Physics and Astronomy00.6%
    6. Earth and Planetary Sciences00.1%
    7. Environmental Science00.1%
    8. Mathematics00.1%
    9. Chemical Engineering00.1%
    1. Economics, Econometrics and Finance11.2%
    2. Business, Management and Accounting10.9%
    3. Arts and Humanities10.8%
    4. Social Sciences10.7%
    5. Decision Sciences00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.47× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.88× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 4.40× its world share, 0 worksImmunology and Micro…Neuroscience: 0.51× its world share, 0 worksNeuroscienceChemistry: 7.05× its world share, 0 worksChemistryEngineering: 0.59× its world share, 0 worksEngineeringHealth Professions: 2.02× its world share, 0 worksHealth ProfessionsMedicine: 1.95× its world share, 1 worksMedicineVeterinary: 3.91× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.82× its world share, 0 worksBusiness, Management…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 7.0×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Chemistry7.05×0 works
  2. Biochemistry, Genetics and Molecular Biology4.88×1 works
  3. Immunology and Microbiology4.40×0 works
  4. Veterinary3.91×0 works
  5. Health Professions2.02×0 works
  6. Medicine1.95×1 works
  7. Business, Management and Accounting0.82×0 works
  8. Engineering0.59×0 works
  9. Neuroscience0.51×0 works
  10. Agricultural and Biological Sciences0.47×0 works
  11. Social Sciences0.04×0 works

Who are the top researchers at Napp Pharmaceuticals (United Kingdom)?

Ranked on the quality score, Rodney Smith, CYRIL BORODA and A. J. Miller lead among researchers whose main affiliation is Napp Pharmaceuticals (United Kingdom).

  1. 1 Rodney Smith United Kingdom · #4,019,755 worldwide 237 citations · 17 works
  2. 2 CYRIL BORODA United Kingdom · #4,328,904 worldwide 65 citations · 16 works
  3. 3 A. J. Miller United Kingdom · #4,615,968 worldwide 838 citations · 62 works
All ranked researchers at Napp Pharmaceuticals (United Kingdom)

What are the most cited papers from Napp Pharmaceuticals (United Kingdom)?

The most cited paper from Napp Pharmaceuticals (United Kingdom) is "Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM" (Ian Hickson, Yan Zhao, Caroline J. Richardson et al., 2004), with 1,227 citations. Next come "Chemistry challenges in lead optimization: silicon isosteres in drug discovery" (429) and "The 'rule of three' for fragment-based drug discovery: where are we now?" (337).

Most cited papers
#PaperReleasedCitations
1 Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM Ian Hickson, Yan Zhao, Caroline J. Richardson et al. · Cancer Research 15 Dec 2004 1,227
2 Chemistry challenges in lead optimization: silicon isosteres in drug discovery Graham A. Showell, JOHN S. MILLS · Drug Discovery Today Jun 2003 429
3 The 'rule of three' for fragment-based drug discovery: where are we now? Harren Jhoti, Glyn Williams, David C. Rees et al. · Nature Reviews Drug Discovery 12 Jul 2013 337
4 Formulation aspects of biodegradable polymeric microspheres for antigen delivery Harjit Tamber, Pål Johansen, Hans Peter Merkle et al. · Advanced Drug Delivery Reviews 4 Oct 2004 316
5 Assessment of Dose Proportionality: Report from the Statisticians in the Pharmaceutical Industry/Pharmacokinetics UK Joint Working Party Kevin A Gough, Michael G. Hutchison, Oliver N. Keene et al. · Drug Information Journal Jul 1995 269
All 60 most cited papers, with filters and sorting

Which keywords describe research at Napp Pharmaceuticals (United Kingdom)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pain Management, Inflammation, Vaccine, Immune Response, Gene Therapy, Postoperative Pain and Chronic Pain.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology13▲ 3.9×33 topics
  2. Inflammation6▲ 3.0×17 topics
  3. Pain Management4▲ 21×5 topics
  4. Vaccine4▲ 11×4 topics
  5. Immune Response3▲ 6.6×5 topics
  6. Treatment3▲ 3.2×7 topics
  7. Gene Therapy3▲ 14×3 topics
  8. Postoperative Pain3▲ 38×3 topics
  9. Chronic Pain3▲ 16×4 topics
  10. AAV3▲ 54×1 topic
  11. Viral Vectors3▲ 54×1 topic
  12. Cancer Therapy3▲ 5.1×10 topics
  13. Pharmacokinetics3▲ 12×4 topics
  14. Clinical Trials2▲ 5.1×6 topics
  15. Diagnosis2▲ 3.1×8 topics
  16. Medicinal Chemistry2▲ 8.1×4 topics
  17. Herpes Zoster2▲ 65×1 topic
  18. Herpesviruses2▲ 65×1 topic
  19. Glycosylation2▲ 13×3 topics
  20. Pathogenesis2▲ 4.9×8 topics
  21. Infection2▲ 9.3×3 topics
  22. Method Validation2▲ 35×2 topics
  23. Pain Assessment Tools2▲ 50×2 topics
  24. Drug Development2▲ 18×3 topics
  25. Green Analytical Chemistry2▲ 27×1 topic
  26. Pharmaceutical Analysis2▲ 80×1 topic
  27. Analgesia2▲ 31×2 topics
  28. Monoclonal Antibodies2▲ 16×3 topics
  29. Adverse Drug Reactions2▲ 32×2 topics
  30. Medication Adherence2▲ 36×2 topics
  31. Therapeutic Antibodies2▲ 17×2 topics
  32. Off-Label Drug Use2▲ 54×1 topic
  33. Pediatric Pharmacokinetics2▲ 54×1 topic
  34. Organometallic Chemistry2▲ 13×3 topics
  35. Perioperative Care2▲ 16×2 topics
  36. Antiepileptic Drugs1▲ 18×2 topics
  37. Genomic Studies1▲ 20×2 topics
  38. Regional Anesthesia1▲ 32×1 topic
  39. Surgical Outcome1▲ 32×1 topic
  40. Cyclodextrins1▲ 73×1 topic

Which research topics does Napp Pharmaceuticals (United Kingdom) publish most on?

By volume in 2022-now: Cancer-related Molecular Pathways, RNA modifications and cancer, Ubiquitin and proteasome pathways and Innovative Approaches in Technology and Social Development.

Cancer-related Molecular…1Cancer-related Molecular Pathways: 1 fractional worksRNA modifications and cancer: 0 fractional worksUbiquitin and proteasome…0Ubiquitin and proteasome pathways: 0 fractional worksInnovative Approaches in Technology and Social Development: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksOxidative Organic Chemistry Reactions: 0 fractional worksInnovative Microfluidic and Catalytic Techniques Innovation: 0 fractional worksinterferon and immune responses: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksCommunity Health and Development: 0 fractional works
OncologyMolecular BiologyManagement of Technology and InnovationBiomedical Engineering3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer-related Molecular Pathways Oncology 1 works
  2. 2 RNA modifications and cancer Molecular Biology 0 works
  3. 3 Ubiquitin and proteasome pathways Molecular Biology 0 works
  4. 4 Innovative Approaches in Technology and Social Development Management of Technology and Innovation 0 works
  5. 5 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  6. 6 Oxidative Organic Chemistry Reactions Organic Chemistry 0 works
  7. 7 Innovative Microfluidic and Catalytic Techniques Innovation Biomedical Engineering 0 works
  8. 8 interferon and immune responses Immunology 0 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 0 works
  10. 10 Community Health and Development General Health Professions 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available17.6%not open82.4%

World: 40% of research is openly available.

with international co-authors20.8%domestic only79.2%

World: 18% is written across borders.

How has Napp Pharmaceuticals (United Kingdom)'s research output changed?

Output in 2022-2025 was 30% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Napp Pharmaceuticals (United Kingdom) as a percentage of every work published that year, 0.0000074% in 2023.

0.00020%0.00040%0.00060%Napp Pharmaceuticals (United Kingdom)0.0000067% in 202419801990200020102020

Fractional works of Napp Pharmaceuticals (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Napp Pharmaceuticals (United Kingdom). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.